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Introduction:
Cystic fibrosis (CF) is the major genetic inherited disease in the European Caucasian
population, with an average of 1 in 3000 living births in France. Prognostic depend
essentially on the lung impairments. While considerable attention therefore has been
paid over recent decades to prevent and treat bacterial respiratory infections, we
observed emergence of fungi colonization in CF respiratory tract. In particular,
Aspergillus fumigatus represents the most common causative agent colonizing the
airways of CF patients; it can be responsible for Allergic Bronchopulmonary
Aspergillosis (ABPA). Since oral corticosteroids and itraconazole represent the
mainstay of ABPA treatment, long-term therapy may increase the risk of acquired
resistance to azoles that is mainly associated with amino acid substitutions in the
CYP51A gene of A. fumigatus.
Objective:
First, we managed to have exhaustive epidemiological data on species of filamentous
fungi able to colonize the airway tract of 300 CF patients followed-up in our national
prospective study ("MucoFong" study – PHRC1902). Second, CF patients being
chronically exposed to azole (especially to itraconazole), our study aimed to evaluate
the prevalence of azole resistance in isolates prospectively collected from CF patients
followed-up in seven French hospitals involved in our national prospective study. Third,
we focused on the most prevalent species: Aspergillus fumigatus, studying the azole
resistance at molecular level. To our knowledge, it is the first multicenter study
focused on azole resistance of A. fumigatus in CF.
Methods:
A total of 243 sputa were analyzed using the same protocol in each centre. The
MICs of antifungal drugs were evaluated for each isolate using the E-test ® strips.
Focusing on A. fumigatus, a total of 87 isolates was collected in 85 patients. These
isolates were characterized at the molecular level by targeting ITS, ß-tubulin and MAT-
A/α genes. The CYP51A gene as well as its promoter was sequenced; a 3D Cyp51A
protein homology model was built.
Results and discussion:
300 patients were enrolled in this study. At inclusion time, most of them were adults
colonized with A. fumigatus (about 35% of the patients). Scedosporium was isolated in
5%, and Exophiala in about 2%. Regarding antifungal susceptibility, isolates of
Scedosporium and Exophiala exhibited antifungal resistance comparable with
published data. Regarding A. fumigatus, a majority of isolates (88.1%) were found
sensitive to itraconazole (MIC≤ 2μg/ml), and 2 new mutations were identified and
localized within 3-dimensional Cyp51A protein model. To obtain insight into azole
resistance of A. fumigatus, the results are analyzed taking into account clinical data,
itraconazole exposition, and the potential correlation between the identified CYP5IA
mutations and azole resistance is discussed based on the Cyp51A protein homology
model.
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